Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Baimai Biotechnology is a specialized biotechnology company focused on the fields of synthetic biology and enzyme engineering. The company develops and manufactures high-performance enzymes and bio-based raw materials used in molecular diagnostics, mRNA vaccine production, and gene sequencing. By utilizing its proprietary protein design and evolution platforms, Baimai Biotech provides a comprehensive portfolio of reagents, including polymerases, ligases, and nucleoside triphosphates. Headquartered in Nanjing, China, the firm serves as a critical supplier to the life sciences and diagnostic industries, offering both standardized products and customized enzyme development services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 南京佰麦生物技术.